Helius Announces FDA 510(k) Submission for PoNS Device Label Expansion in Stroke

Image for article Helius Announces FDA 510(k) Submission for PoNS Device Label Expansion in Stroke
News Source : Financial Post

News Summary

  • Helius Medical Technologies, Inc. (NASDAQ: HSDT) announced the filing of its U.S. Food and Drug Administration (FDA) 510(k) submission for the PoNS (Portable Neuromodulation Stimulator) device label expansion.
  • The submission was made with data generated in its Stroke Registrational Program (SRP) and was filed under its current FDA Breakthrough Device Designation.
  • PoNS efficacy and safety was clinically established from three clinical trials across 10 sites and 159 enrolled chronic stroke survivors with gait deficit due to stroke.
The Company has adopted adigital assettreasury strategy focused on accumulating SOL, the nativedigital assetof theSolanablockchain, leveraging capital markets raises that produce consistent on [+2883 chars]

Must read Articles